Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1980-05-15
1981-08-04
Cacciapaglia, Jr., Frank
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
A61K 3119
Patent
active
042822521
ABSTRACT:
Novel treatments are disclosed for increasing circulating coronary blood flow. These treatments are useful for individuals who are expected to otherwise exhibit symptoms of reduced coronary circulation. Such individuals include those having coronary artery disease, angina, particularly unstable angina and Prinzmetal's angina, and coronary vasospasm. In accordance with the disclosed methods, coronary vasodilation is accomplished through the administration of effective amounts of buiprofen and/or flurbiprofen. At the indicated dosages, thromboxane synthesis is effectively inhibited without inhibiting prostacyclin synthesis. Flurbiprofen administration additionally results in thromboxane antagonism.
REFERENCES:
Davies et al., Drugs, 2: 416-446, (1971).
Brooks et al., Current Therapeutic Res. 15(4), 180-181, (1973).
MacLean et al., Clinical Res., 25: 455A, (1977).
Judgutt et al., Am. J. Cardiol., 43: 393, (1979).
Lefer et al., Cardiology 64: 265-279, (1979).
Lefer et al., Advances in Shock Research, 3: 133-141, (1980).
Cacciapaglia, Jr. Frank
Thomas Jefferson University
LandOfFree
Method of increasing coronary blood flow with ibuprofen does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of increasing coronary blood flow with ibuprofen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of increasing coronary blood flow with ibuprofen will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-240456